Toll-Like Receptor 4 Mediates Lung Ischemia-Reperfusion Injury

Annals of Thoracic Surgery

Volumn 82, Issue 6, 2006, Pages 2017-2023

  Shimamoto, Akira ^a   Pohlman, Timothy H ^b   Shomura, Shin ^a   Tarukawa, Tomohito ^a   Takao, Motoshi ^a   Shimpo, Hideto ^a  

^a MIE UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b INDIANA UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BOVINE SERUM ALBUMIN; CHEMOKINE; CYTOKINE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; IODINE 125; MITOGEN ACTIVATED PROTEIN KINASE; MYELOPEROXIDASE; STRESS ACTIVATED PROTEIN KINASE; TOLL LIKE RECEPTOR 4; TRANSCRIPTION FACTOR AP 1;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLOOD VESSEL PERMEABILITY; CELL NUCLEUS; CONTRAST MEDIUM EXTRAVASATION; CONTROLLED STUDY; CYTOKINE PRODUCTION; ENZYME ACTIVITY; ENZYME PHOSPHORYLATION; INTRACELLULAR TRANSPORT; ISCHEMIA; LUNG BLOOD FLOW; LUNG HOMOGENATE; LUNG ISCHEMIA; LUNG LAVAGE; MALE; MOUSE; NEUTROPHIL CHEMOTAXIS; NONHUMAN; PNEUMONIA; PRIORITY JOURNAL; PROTEIN FUNCTION; PROTEIN TRANSPORT; REPERFUSION INJURY; WILD TYPE;

ANIMALS; CAPILLARY PERMEABILITY; DISEASE MODELS, ANIMAL; LUNG DISEASES; MALE; MICE; MICE, KNOCKOUT; NF-KAPPA B; REPERFUSION INJURY; TOLL-LIKE RECEPTOR 4; TRANSCRIPTION FACTOR AP-1;

EID: 33751184386     PISSN: 00034975     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.athoracsur.2006.06.079     Document Type: Article

References (32)

1. Meyers B.F., Lynch J., Trulock E.P., Guthrie T.J., Cooper J.D., and Patterson G.A. Lung transplantation: a decade of experience. Ann Surg 230 (1999) 362-371
2. Fiser S.M., Tribble C.G., Long S.M., et al. Ischemia-reperfusion injury after lung transplantation increases risk of late bronchiolitis obliterans syndrome. Ann Thorac Surg 73 (2002) 1041-1048
3. Herskowitz A., Choi S., Ansari A.A., and Wesselingh S. Cytokine mRNA expression in postischemic/reperfused myocardium. Am J Pathol 146 (1995) 419-428
4. Chong A.J., Shimamoto A., Hampton C.R., et al. Toll-like receptor 4 mediates ischemia/reperfusion injury of the heart. J Thorac Cardiovasc Surg 128 (2004) 170-179
5. Oyama J., Blais Jr. C., Liu X., et al. Reduced myocardial ischemia-reperfusion injury in toll-like receptor 4-deficient mice. Circulation 109 (2004) 784-789
6. Tsung A., Sahai R., Tanaka H., et al. The nuclear factor HMGB1 mediates hepatic injury after murine liver ischemia-reperfusion. J Exp Med 201 (2005) 1135-1143
7. Ishiyama T., Dharmarajan S., Hayama M., Moriya H., Grapperhaus K., and Patterson G.A. Inhibition of nuclear factor kappaB by IkappaB superrepressor gene transfer ameliorates ischemia-reperfusion injury after experimental lung transplantation. J Thorac Cardiovasc Surg 130 (2005) 194-201
8. Shimamoto A., Chong A.J., Yada M., et al. Inhibition of Toll-like receptor 4 with eritoran attenuates myocardial ischemia-reperfusion injury. Circulation 114 1 Suppl (2006) I270-I274
9. Hoshino K., Takeuchi O., Kawai T., et al. Cutting edge: Toll-like receptor 4 (TLR4)-deficient mice are hyporesponsive to lipopolysaccharide: evidence for TLR4 as the Lps gene product. J Immunol 162 (1999) 3749-3752
10. Okada K., Fujita T., Minamoto K., Liao H., Naka Y., and Pinsky D.J. Potentiation of endogenous fibrinolysis and rescue from lung ischemia/reperfusion injury in interleukin (IL)-10-reconstituted IL-10 null mice. J Biol Chem 275 (2000) 21468-21476
11. Guha M., and Mackman N. LPS induction of gene expression in human monocytes. Cell Signal 13 (2001) 85-94
12. Okada Y., and Kondo T. Impact of lung preservation solutions, Euro-Collins vs. low-potassium dextran, on early graft function: a review of five clinical studies. Ann Thorac Cardiovasc Surg 12 (2006) 10-14
13. Hermle G., Schutte H., Walmrath D., Geiger K., Seeger W., and Grimminger F. Ventilation-perfusion mismatch after lung ischemia-reperfusion. Protective effect of nitric oxide. Am J Respir Crit Care Med 160 (1999) 1179-1187
14. Schnare M., Rollinghoff M., and Qureshi S. Toll-like receptors: sentinels of host defence against bacterial infection. Int Arch Allergy Immunol 139 (2006) 75-85
15. Poltorak A., He X., Smirnova I., et al. Defective LPS signaling in C3H/HeJ and C57BL/10ScCr mice: mutations in Tlr4 gene. Science 282 (1998) 2085-2088
16. Frantz S., Kobzik L., Kim Y.D., et al. Toll4 (TLR4) expression in cardiac myocytes in normal and failing myocardium. J Clin Invest 104 (1999) 271-280
17. Schuster J.M., and Nelson P.S. Toll receptors: an expanding role in our understanding of human disease. J Leukoc Biol 67 (2000) 767-773
18. Gaur U., and Aggarwal B.B. Regulation of proliferation, survival and apoptosis by members of the TNF superfamily. Biochem Pharmacol 66 (2003) 1403-1408
19. Moynagh P.N. The NF-kappaB pathway. J Cell Sci 118 (2005) 4589-4592
20. Moynagh P.N. TLR signalling and activation of IRFs: revisiting old friends from the NF-kappaB pathway. Trends Immunol 26 (2005) 469-476
21. Li C., Ha T., Kelley J., et al. Modulating Toll-like receptor mediated signaling by (1→3)-beta-D-glucan rapidly induces cardioprotection. Cardiovasc Res 61 (2004) 538-547
22. Bonizzi G., and Karin M. The two NF-kappaB activation pathways and their role in innate and adaptive immunity. Trends Immunol 25 (2004) 280-288
23. Scaffidi P., Misteli T., and Bianchi M.E. Release of chromatin protein HMGB1 by necrotic cells triggers inflammation. Nature 418 (2002) 191-195
24. Park J.S., Gamboni-Robertson F., He Q., et al. High mobility group box 1 protein interacts with multiple Toll-like receptors. Am J Physiol Cell Physiol 290 (2006) C917-C924
25. Johnson G.B., Brunn G.J., Kodaira Y., and Platt J.L. Receptor-mediated monitoring of tissue well-being via detection of soluble heparan sulfate by Toll-like receptor 4. J Immunol 168 (2002) 5233-5239
26. Smiley S.T., King J.A., and Hancock W.W. Fibrinogen stimulates macrophage chemokine secretion through toll-like receptor 4. J Immunol 167 (2001) 2887-2894
27. Termeer C., Benedix F., Sleeman J., et al. Oligosaccharides of Hyaluronan activate dendritic cells via toll-like receptor 4. J Exp Med 195 (2002) 99-111
28. Triantafilou M., and Triantafilou K. Heat-shock protein 70 and heat-shock protein 90 associate with Toll-like receptor 4 in response to bacterial lipopolysaccharide. Biochem Soc Trans 32 (2004) 636-639
29. Vabulas R.M., Ahmad-Nejad P., Ghose S., Kirschning C.J., Issels R.D., and Wagner H. HSP70 as endogenous stimulus of the Toll/interleukin-1 receptor signal pathway. J Biol Chem 277 (2002) 15107-15112
30. Williams D.L., Ha T., Li C., Laffan J., Kalbfleisch J., and Browder W. Inhibition of LPS-induced NFkappaB activation by a glucan ligand involves down-regulation of IKKbeta kinase activity and altered phosphorylation and degradation of IkappaBalpha. Shock 13 (2000) 446-452
31. Mullarkey M., Rose J.R., Bristol J., et al. Inhibition of endotoxin response by e5564, a novel Toll-like receptor 4-directed endotoxin antagonist. J Pharmacol Exp Ther 304 (2003) 1093-1102
32. Wong Y.N., Rossignol D., Rose J.R., Kao R., Carter A., and Lynn M. Safety, pharmacokinetics, and pharmacodynamics of E5564, a lipid A antagonist, during an ascending single-dose clinical study. J Clin Pharmacol 43 (2003) 735-742